BCL2 and neoplasm: In the increasingly hypoxic tumour environment, cells with the potential to evade cell death are enriched by the induction of anti-apoptotic proteins such as B-cell lymphoma 2 (BCL-2)26–28 and hypoxia-inducible factor 1-alpha (HIF1A)29.